- Home
- XTNT vs DTF Comparison
XTNT vs DTF Comparison
Compare XTNT & DTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- DTF
- Stock Information
- Founded
- XTNT N/A
- DTF 1991
- Country
- XTNT United States
- DTF United States
- Employees
- XTNT N/A
- DTF N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- DTF Investment Managers
- Sector
- XTNT Health Care
- DTF Finance
- Exchange
- XTNT Nasdaq
- DTF Nasdaq
- Market Cap
- XTNT 69.3M
- DTF 79.4M
- IPO Year
- XTNT N/A
- DTF N/A
- Fundamental
- Price
- XTNT $0.59
- DTF $11.25
- Analyst Decision
- XTNT Strong Buy
- DTF
- Analyst Count
- XTNT 1
- DTF 0
- Target Price
- XTNT $3.00
- DTF N/A
- AVG Volume (30 Days)
- XTNT 83.6K
- DTF 21.1K
- Earning Date
- XTNT 11-12-2024
- DTF 01-01-0001
- Dividend Yield
- XTNT N/A
- DTF 3.64%
- EPS Growth
- XTNT N/A
- DTF N/A
- EPS
- XTNT N/A
- DTF 0.44
- Revenue
- XTNT $113,862,000.00
- DTF N/A
- Revenue This Year
- XTNT $31.27
- DTF N/A
- Revenue Next Year
- XTNT $13.07
- DTF N/A
- P/E Ratio
- XTNT N/A
- DTF $24.34
- Revenue Growth
- XTNT 45.11
- DTF N/A
- 52 Week Low
- XTNT $0.33
- DTF $10.29
- 52 Week High
- XTNT $1.30
- DTF $11.19
- Technical
- Relative Strength Index (RSI)
- XTNT 73.52
- DTF 53.61
- Support Level
- XTNT $0.49
- DTF $11.13
- Resistance Level
- XTNT $0.55
- DTF $11.31
- Average True Range (ATR)
- XTNT 0.07
- DTF 0.05
- MACD
- XTNT 0.01
- DTF 0.01
- Stochastic Oscillator
- XTNT 95.48
- DTF 66.12
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
About DTF DTF Tax-Free Income 2028 Term Fund Inc.
DTF Tax-Free Income 2028 Term Fund Inc is a diversified closed-end management investment company. The Fund's investment objective is current income exempt from regular federal income tax consistent with the preservation of capital. It seeks to achieve its investment objective by investing primarily in a diversified portfolio of investment-grade tax-exempt obligations.